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Abstract
Background: Adult mesenchymal stem cells (MSCs) play a crucial role in the maintenance of tissue homeostasis
and in regenerative processes. Among the different MSC types, the gingiva-derived mesenchymal stem cells
(GMSCs) have arisen as a promising tool to promote the repair of damaged tissues secreting trophic mediators that
affect different types of cells involved in regenerative processes. Tumour necrosis factor (TNF)-α is one of the key
mediators of inflammation that could affect tissue regenerative processes and modify the MSC properties in
in-vitro applications. To date, no data have been reported on the effects of TNF-α on GMSC trophic activities and
how its modulation with anti-inflammatory agents from natural sources could modulate the GMSC properties.
Methods: GMSCs were isolated and characterized from healthy subjects. The effects of TNF-α were evaluated on
GMSCs and on the well-being of endothelial cells. The secretion of cytokines was measured and related to the
modification of GMSC-endothelial cell communication using a conditioned-medium method. The ability to modify
the inflammatory response was evaluated in the presence of Ribes nigrum bud extract (RBE).
Results: TNF-α differently affected GMSC proliferation and the expression of inflammatory-related proteins
(interleukin (IL)-6, IL-10, transforming growth factor (TGF)-β, and cyclooxygenase (COX)-2) dependent on its
concentration. A high TNF-α concentration decreased the GMSC viability and impaired the positive cross-talk
between GMSCs and endothelial cells, probably by enhancing the amount of pro-inflammatory cytokines in the
GMSC secretome. RBE restored the beneficial effects of GMSCs on endothelial viability and motility under
inflammatory conditions.
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Conclusions: A high TNF-α concentration decreased the well-being of GMSCs, modifying their trophic activities
and decreasing endothelial cell healing. These data highlight the importance of controlling TNF-α concentrations to
maintain the trophic activity of GMSCs. Furthermore, the use of natural anti-inflammatory agents restored the
regenerative properties of GMSCs on endothelial cells, opening the way to the use and development of natural
extracts in wound healing, periodontal regeneration, and tissue-engineering applications that use MSCs.
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Background
Tissue regeneration is a dynamic process divided into
different organized stages: haemostasis, an inflammatory
phase, proliferation, and maturation/matrix remodelling
[1, 2]. All these phases require cell-to-cell interactions
orchestrated by growth factors, cytokines, and extracel-
lular matrix (ECM) components [3], and a dysregulation
of these mediators could lead to a pathological wound
healing and fibrosis [4]. Among the different phases,
several cell types are involved including mesenchymal
stem cells (MSCs), endothelial cells, immune cells, and
fibroblasts. During the initial stages, plenty of pro-
inflammatory factors are released by resident or immune
cells attracted to the site of injury [5] that play a role in
the activation of MSC-driven tissue repair and angiogen-
esis. Among these inflammatory factors, tumour necrosis
factor (TNF)-α is of great interest for its ability to influ-
ence the properties of MSCs [6, 7], varying the secretion
of soluble mediators that could interfere with endothelial
functionality and tissue regeneration [8]. TNF-α is con-
sidered a pleiotropic cytokine with diverse effects that
range from triggering proliferation to inducing apop-
tosis, dependent on cell type, status, environment, time,
and dose of exposure [9, 10]. Thus, the effects of differ-
ent concentrations of TNF-α on the gingiva-derived
MSC (GMSC) subtype could be of great interest for
scientists in the field of regenerative medicine.
Stem cell biology has become an important field in re-
generative medicine and tissue engineering therapy since
the discovery and characterization of MSCs. MSCs
represent a population of multipotent stem cells that
can be isolated from many tissues [11, 12]. The isolation
of MSCs produces heterogeneous, non-clonal cultures of
stromal cells containing stem cells with different multi-
potential properties, committed progenitors, and differ-
entiated cells [13]. However, cultures obtained from
bone marrow (BM) and other tissues that contain a
subpopulation of stem cells are currently serving as a
valuable source of accepted MSCs for therapeutic pur-
poses [14, 15]. Among the different population of stem
cells, GMSCs have attracted great attention due to their
easy accessibility from the oral cavity [16, 17]. GMSCs
are stem cells derived from the neuronal crest; besides
the well-established self-renewal, multipotent differenti-
ation, and immunomodulatory properties, GMSCs, simi-
lar to other MSCs, possess trophic activity which could
be of great therapeutic interest [18]. Gingival tissues also
exhibit scarless wound healing properties and a high
regenerative capability, highlighting these cells as an
attractive therapeutic option to enhance wound repair in
oral and extra-oral tissues [19, 20].
Despite efforts towards the discovery of agents and
mechanisms that could modulate and promote regener-
ation, to date several issues remain to be resolved. In
fact, the development of an adequate vascular network
remains one of the major challenges in tissue regener-
ation [21]. Although tissue engineering has provided
scaffolds that are widely used in clinics for skin wound
healing [22] and periodontal regeneration [23, 24], the
limitation of oxygen diffusion remains a key issue. Thus,
improvement of angiogenic processes to provide
adequate blood supply for cells under proliferation could
represent a pivotal milestone. In this scenario, the use of
natural products that are able to directly improve the
functions of the endothelial cells or to modulate the cell
microenvironment has become as a promising tool.
Over the last decade, much research has highlighted
the beneficial role of fruit and vegetable consumption in
lowering the risk for developing chronic inflammation
[25, 26]. The Ribes nigrum L. (blackcurrant) is a small,
perennial shrub that belongs to the family Grossulariaceae.
The R. nigrum bud extract (RBE) contain vitamins, terpe-
nic, and phenolic compounds, including flavonols, phen-
olic acids, and catechins at high concentrations [27, 28].
The blackcurrant has been shown to exhibit several bio-
logical properties, such as anti-microbial, anti-oxidant and
anti-inflammatory activities [29]. Interestingly, the in-vitro
administration of a berry and leaf extract is able to con-
trast the effects of TNF-α and to modulate the cytokine
release of monocytes [30]. The ability to modulate in-
flammatory pathologies and the positive effects against
dermal diseases (eczema and psoriasis) [29, 31] shows
the potential effect of the extract in the regeneration of
injured tissues.
To date, no data have been reported on the effects of
TNF-α on GMSC trophic properties and how its
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modulation with anti-inflammatory agents from natural
sources could restore the GMSC functions. Thus, the aim
of this work was to investigate the effects of TNF-α on the
well-being of GMSCs and on the GMSC/endothelial cell
interplay. Furthermore, the possibility of using a natural
extract (RBE) to restore the physiological trophic proper-
ties of GMSCs was evaluated.
TNF-α differently affected the GMSC proliferation and
expression of inflammatory-related proteins dependent
on its concentration. A high TNF-α concentration pro-
duced an increase in pro-inflammatory proteins, redu-
cing the positive effects of the GMSC secretome on
endothelial cells. RBE, which was rich in phenol constit-
uents with anti-inflammatory activity, was able to affect
the GMSC release of inflammatory mediators, thus re-
storing endothelial cell migration and healing under
physiological and pathological conditions.
Methods
Materials
A hydro-alcoholic glycerine solution of R. nigrum buds
(1.5%) was kindly provided by Biokyma S.r.l. (Anghiari,
Arezzo, Italy). The RNeasy® Mini Kit was obtained from
Qiagen S.p.A. The iScript cDNA synthesis kit was
purchased from Bio-rad s.r.l. Fluocycle® II SYBR® was
purchased from Euroclone s.p.a. (Milan, Italy). TNF-α
was purchased from Sigma Aldrich (Milan, Italy). High-
performance liquid chromatography (HPLC)-grade water
(18 mΩ) was prepared by a Mill-Ω50 purification system
(Millipore Corp., Bedford, MA, USA). All the reagents
and materials were obtained from commercial sources
with a high grade of purity.
Isolation and culture of human GMSCs
GMSCs were obtained after processing de-keratinized gin-
gival tissues previously collected from four healthy female
patients (average age 35.5 years) undergoing clinical crown
lengthening procedures. The protocol received approval
from the ethical committee of the University Hospital of
Pisa (Pisa, Italy; protocol no. 32835/2016) and informed
consent was obtained from the included patients.
The tissues were processed as previously reported with
a few modifications [32]. Briefly, after surgical removal,
discharged gingival specimens were de-epithelialized and
placed in sterile phosphate-buffered saline (PBS) with
100 U/mL penicillin and 100 μg/mL streptomycin
(Sigma-Aldrich, Milan, Italy) at 4 °C. The tissues were
minced into 1–2 mm2 fragments and digested in Dulbecco’s
modified Eagle’s medium (DMEM)-F12 containing dispase
(1 mg/mL; Sigma-Aldrich) and collagenase IV (2 mg/mL;
Sigma-Aldrich) at 37 °C for 30 min. Then, the suspension
was discarded, and the remained tissues were digested in
the same solution for 90 min at 37 °C. The solution was
then filtered with a 70-μm cell strainer (Sigma-Aldrich)
and seeded with DMEM-F12 containing 10% fetal bovine
serum (FBS), 100 U/mL penicillin, 100 μg/mL strepto-
mycin, and 200 mM L-glutamine in a 25-cm2 tissue
culture flask. At 24 h after isolation, the non-adherent
cells were washed with PBS and replaced with fresh
medium (passage 0).
Cell cultures
The isolated GMSCs were maintained in growth medium
(DMEM-F12 containing 10% FBS, 100 U/mL penicillin,
100 μg/mL streptomycin, 200 mM L-glutamine) and incu-
bated at 37 °C in 5% CO2 and 95% air. The medium was
changed to remove non-adherent cells every 3 to 4 days
and the cells were used at passages 0 to 6.
Human dermal fibroblasts cells (HuDe; purchased
from the Istituto Zooprofilattico Sperimentale, Brescia,
Italy) were maintained in DMEM-F12 containing 10%
FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and
200 mM L-glutamine, and incubated at 37 °C in 5% CO2
and 95% air. The medium was changed to remove non-
adherent cells every 3 to 4 days and the cells were used
at passages 0 to 20.
The immortalized human microvascular endothelial cell
line (HMEC-1) was obtained from ATCC and maintained
in a culture medium of MCDB131 (without L-glutamine),
10 ng/mL epidermal growth factor (EGF), 10 μg/mL
hydrocortisone, 10 mM L-glutamine, and 10% FBS. Cells
were maintained in a 37 °C humidified incubator with 5%
CO2. The medium was changed to remove non-adherent
cells every 3 to 4 days and the cells were used at passages
10 to 18.
Colony-forming unit-fibroblast (CFU-F) assay and
doubling time
For CFU-F assay, the GMSCs were plated into a six-well
plate at densities of 500 or 1000 cell/well and main-
tained in growth medium. After 14 days, the cells were
fixed with 4% paraformaldehyde (Sigma-Aldrich) and
stained with 1% crystal violet. Groups of ≥ 50 cells were
scored as a CFU-F colony. The numbers of colonies
were statistically evaluated.
The assessment of the GMSC doubling time was per-
formed as previously described [33]. Cells of different
passages were seeded onto 12-well plates at 103 cells/
well in growth media and the cells in each well were
scored at 24, 48, 72, and 96 h. Population doubling was
calculated using: number of divisions = log2 (number of
cells at subculture/number of cells seeded).
PCR and real-time RT-PCR analysis
GMSC surface markers were analysed with polymerase
chain reaction (PCR). The PCR reaction was conducted
following the manufacturer’s instructions (GoTaq G2
Flexi DNA Polymerase, Promega) and with the following
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reagents: 5 μL GoTaq Flexi Buffer, 1.5 μL MgCl2
(25 mM), 0.5 μL PCR Nucleotide Mix (10 mM), 0.5 μL
of forward and reverse primers (10 μM; Table 1), 0.2 μL
GoTaq G2 Flexi DNA Polymerase (5 U/μL), 500 ng
cDNA, and 11.8 μL H2O. The reactions were performed
for 40 cycles using the following temperature profiles:
95 °C for 2 min; 55 °C for 30 s, and 72 °C for 5 min.
β-actin was used as the housekeeping gene.
The gene expression of GMSCs and HMECs were quan-
tified by performing a real-time reverse transcription
(RT)-PCR analysis. Briefly, GMSCs (5.0 × 103 cell/cm2) or
HMECs (1.0 × 104 cell/cm2) were treated with glycerine-
ethanol solution or RBE (50 μg/mL) in the absence or the
presence of TNF-α (1 ng/mL or 10 ng/mL) for the indi-
cated times. The cells were collected, and the total RNA
was extracted using the Rneasy® Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
The purity of the RNA samples was determined by meas-
uring the absorbance at 260/280 nm. cDNA synthesis was
then performed with 500 ng RNA using the i-Script cDNA
synthesis kit following the manufacturer’s instructions.
Real-time RT-PCR reactions consisted of 25 μL Fluocycle®
II SYBR®, 1.5 μL of both 10 μM forward and reverse
primers, 3 μL cDNA, and 19 μL H2O. All reactions were
performed for 40 cycles using the following temperature
profiles: 98 °C for 30 s; 55 °C for 30 s; and 72 °C for 3 s.
The primers used were designed to span intron/exon
boundaries and β-actin was used as the housekeeping gene.
The mRNA levels for each sample were normalized against
β-actin mRNA levels, and the relative expression was cal-
culated using a Ct value. PCR specificity was determined
by both melting curve analysis and gel electrophoresis.
Immunofluorescence analysis of stem cell markers
GMSCs were seeded in an eight-chamber slide at a density
of 5 × 103 cells/chamber and incubated overnight. The next
day, the cells were fixed with 2% paraformaldehyde (Sigma-
Aldrich), and then permeabilized in 1% Triton- X100 with
PBS for 3 min. GMSCs were stained with anti-CD90
(Millipore, cat. no. CBL415) and Alexa-Fluor-488-
conjugated goat anti-mouse. Non-specific binding was
controlled by omitting the primary antibody or by substi-
tuting the same concentration of non-specific isotype im-
munoglobulin (data not shown). Nuclei were stained with
DAPI (1:5000 dilution; Sigma-Aldrich). The specimens
were mounted in VECTASHIELD_ Mounting Medium
with DAPI (Vector laboratories) and then observed under
a fluorescence microscope (Axiovert 200; Zeiss).
Table 1 Primers used for real-time RT-PCR
Gene Primer nucleotide sequences Product size (base pairs) Annealing temperature
CD34 Forward: 5’-GCCTGGAGCAAAATAAGACCTC-3’
Reverse: 5’-AGGATCCCCAGCTTTTTCAGG-3′
250 bp 55 °C
CD45 Forward: 5’-TGTGGAGCCAATCCATGCAGA-3’
Reverse: 5’-GTTTGACCCTGCATCTCCGTT-3′
232 bp 55 °C
CD90 Forward: 5’-CACACATACCGCTCCCGAA-3’
Reverse: 5’-CACCAGTCACAGGGACATGAA-3′
279 bp 55 °C
CD105 Forward: 5’-ATACCACTAGCCAGGTCTCGAA-3’
Reverse: 5’-ATGGCAGCTCTGTGGTGTTG-3′
288 bp 55 °C
NF-kB Forward: 5′-CAGCAGATGGCCCATACCTT-3′
Reverse: 5′-CACCATGTCCTTGGGTCCAG-3′
287 bp 55 °C
mTOR Forward: 5′-GCCCCTACATGGAGCCTATTC-3′
Reverse: 5′-CCTGGAGCATGTCCATGATGA-3′
183 bp 55 °C
Oct4 Forward: 5’-CTCACCCTGGGGGTTCTATT-3’
Reverse: 5’-CTCCAGGTTGCCTCTCACTC-3’
230 bp 55 °C
SOX2 Forward: 5′-CATGAAGGAGCACCCGGATT-3′
Reverse: 5′-ATGTGCGCGTAACTGTCCAT-3′
186 bp 55 °C
TNF-α Forward: 5′-AGGGACCTCTCTCTAATCAGCC-3′
Reverse: 5′-GCTTGAGGGTTTGCTACAACA-3′
101 bp 55 °C
IL-6 Forward: 5′-TCCTCGACGGCATCTCA-3′
Reverse: 5′-TTTTCACCAGGCAAGTCTCCT-3′
165 bp 55 °C
COX-2 Forward: 5′-TGTGTTGACATCCAGATCACAT-3′
Reverse: 5′-GGAGTCGGGCAATCATCAGG-3′
237 bp 55 °C
IL-10 Forward: 5′-CAAGCTGAGAACCAAGACCC-3′
Reverse: 5′-AAGATGTCAAACTCACTCATGGC-3′
141 bp 55 °C
TGF-β Forward: 5′-ACTGCAAGTGGACATCAACG-3′
Reverse: 5′-TGCGGAAGTCAATGTACAGC-3′
218 bp 55 °C
β-actin Forward: 5’-GCACTCTTCCAGCCTTCCTTCC-3’
Reverse: 5’-GAGCCGCCGATCCACACG-3’
254 bp 55 °C
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Western blot analysis
The protein expression of the surface marker CD90 was
detected in GMSCs by performing a Western blot
analysis. Cells were lysed for 60 min at 4 °C by the
addition of 200 μL RIPA buffer. Equal amounts of the
cell extracts (35 μg of proteins) were diluted in a
Laemmli solution, resolved by SDS-PAGE (15%), and
then transferred to PVDF membranes and probed over-
night at 4 °C with primary antibody anti-CD90 (diluted
1:100; Millipore, cat no. CBL415) or β-actin (diluted 1:
1000; MAB1501, Merck KGaA, Darmstadt, Germany).
The primary antibodies were then detected using anti-
rabbit IgG light chains conjugated to peroxidase (diluted
1:5000; 12–348; Millipore). The peroxidase was detected
using a chemiluminescent substrate (ECL, Perkin Elmer),
and the images were acquired by photographic film or by
LAS4010 (GE Health Care Europe, Uppsala, Sweden).
Immunoreactive bands were quantified by performing a
densitometric analysis with Image J Software (version 1.41;
Bethesda, MD, USA).
Mineralization assay
GMSCs were seeded (3 × 103 cells/cm2) in growth media.
After 24 h the media was replaced with osteogenic-
induction medium (Euroclone) containing dexamethasone
(10−8 M), L-glutamine, ascorbate (50 μg/mL), penicillin/
streptomycin (2 mM), and β-glycerophosphate (2 mM).
As controls, GMSCs were cultured in growth medium.
The medium was changed every 3 days and the
mineralization was quantified after 15 or 21 days of treat-
ment. The rate of mineralization was quantified using
Alizarin Red staining as previously reported [34] with a
few modifications. Briefly, cells were washed with PBS,
fixed (4% formaldehyde in PBS) for 15 min, and then cells
were stained with Alizarin Red S (1:100 in distilled water,
adjusted to pH 4.2, and filtered), washed (five times) in
50% ethanol, and air dried. For quantification, cells were
destained overnight in 10% (w/v) cetylpyridinium chloride
at room temperature with continuous agitation and the
absorbance (562 nm) was read using a spectrophotometer
(Victor Wallac 2, Perkin Elmer).
Cell viability assays
GMSCs and HMEC-1 were seeded in 96-well micro-
plates (3.0 × 103 cells/well) and treated with different
concentrations of RBE (100 ng/mL to 100 μg/mL) or
TNF-α (1–100 ng/mL) alone or in combination for 24,
48, or 72 h. Following the treatment period, cell prolifer-
ation was determined using an MTS assay (CellTiter 96
AQueous One Solution Cell Proliferation Assay kit;
Promega) according to the manufacturer’s instructions.
The absorbance of formazan at 490 nm was measured in
a colorimetric assay with an automated plate reader
(Victor Wallac 2, Perkin Elmer).
The cytotoxicity was assessed by a neutral red assay.
Briefly, cells treated as above were incubated for 1 h with
100 μL of neutral red dye (33 μg/mL) dissolved in serum-
free medium. At the end of the incubation period, cells
were washed twice with the warm PBS solution. The cell-
incorporated dye was solubilized in 100 μL of neutral red
assay solubilization solution (50% EtOH and 1% AcOH).
The cultures were allowed to stand for 10 min at room
temperature with gentle shaking. The absorbance was
measured at a wavelength of 540 nm. The background ab-
sorbance of multiwell plates at 690 nm was subtracted
from the measurement at 540 nm.
Analysis of apoptosis
For apoptosis measurements, GMSCs and HMEC-1
(5.0 × 103 cell/cm2) were treated with or without
TNF-α (100 ng/mL) for 72 h. The percentages of living,
apoptotic, and dead cells were then quantified and analysed
by the Muse™ Cell Analyzer (Merck KGaA, Darmstadt,
Germany). The live, early apoptotic, and late apoptotic/
dead cells were discriminated between using staining with
Annexin V and 7-aminoactinomycin D (7-AAD).
The protein-protein interaction networks (PPIN)
Network analysis was performed using the STRING
(Search Tool for the Retrieval of Interacting Genes/
Proteins) website (http://string-db.org/). The co-mentions,
co-expression, and associations were set as the evidence for
functional links with a medium confidence score of 0.4.
Cytokine release
GMSCs were treated with glycerine-ethanol solution
(control) or RBE (50 μg/mL) in the absence or the pres-
ence of TNF-α (1 ng/mL or 10 ng/mL) for 24 h. The
amounts of cytokines presented in the culture medium
(interleukin (IL)-6, IL-10, and transforming growth
factor (TGF)-β) or expressed on the cell membrane
(cyclooxygenase (COX)-2) was measured using enzyme-
linked immunosorbent assay (ELISA) kits (Thermo
Fisher Scientific, Rodano, Milan, Italy, Enzo Lifescience)
following the manufacturers’ instructions.
Wound healing analysis
GMSCs (5.0 × 103 cell/cm2) were treated with glycerine-
ethanol solution or RBE (50 μg/mL) in the absence or
the presence of TNF-α (1 ng/mL or 10 ng/mL) for 24 h.
Media from GMSCs were collected, and conditioned
media in the proportion of 20% + 80% (20% GMSC con-
ditioned media + 80% HMEC-1 culture media) were
applied onto HMEC-1.
HMEC-1 were seeded in 96-well plates and grown to
90% confluence. A scratch was then made through the
cell layer using a sterile micropipette tip. After washing
with PBS, cells were treated with condition media from
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GMSCs treated as above. The images of the wounded
area were captured immediately after the scratch (t0)
and 8 h later (t8) to monitor cell regeneration into the
wounded area. Photographs were then taken at 10×
magnification on an inverted microscope. The wound-
healing abilities were quantified by measuring both the
average gap width and the percentage of gap closed. The
data were analysed with Image J software.
HPLC-PDA/UV-ESI-MS/MS analysis
For the HPLC-photodiode array (PDA)/UV-electrospray
ionization (ESI) - tandem mass spectrometry (MS/MS)
(HPLC-PDA/UV-ESI-MS/MS) study, 500 μL of a hydro-
alcoholic glycerine solution of R. nigrum buds was added to
1.5 mL of methanol and the mixture was first centrifuged,
then filtered and injected into the LC-MS system. Qualita-
tive HPLC-PDA/UV-ESI-MS/MS analysis was performed
using a Surveyor LC pump, a Surveyor autosampler,
coupled with a Surveyor PDA detector, and a LCQ Advan-
tage ion trap mass spectrometer (ThermoFinnigan, San
Jose, CA, USA) equipped with Xcalibur 3.1 software. Ana-
lysis was performed using a 4.6 × 250 mm, 4-μm, Synergi
POLAR-RP 80A column (Phenomenex, Castel Maggiore,
Bologna, Italy). The eluent was a mixture of methanol
(solvent A) and a 0.1% aqueous solution of formic acid
(solvent B). The solvent gradient was as follows: 0–5 min,
5–50%; 5–25 min, 50% A isocratic mode; 25–85 min, 50–
100% A. Elution was performed at a flow rate of 0.8 mL/
min with a splitting system of 2:8 to MS detector (160 μL/
min) and PDA detector (640 μL/min), respectively. The
volume of the injected methanol solution was 20 μL. Ana-
lyses were performed with an ESI interface in the negative
mode. The ionization parameters used were as follows: ca-
pillary temperature, 270 °C; capillary voltage, −16.0 V;
tube lens offset, −5 V; sheath gas flow rate, 60.00 arbitrary
units; auxiliary gas flow rate, 3.00 arbitrary units; spray
voltage, 4.50 kV; scan range of m/z 150–1200 [35]. N2 was
used as the sheath and auxiliary gas. PDA data were re-
corded in the 200–600 nm range, with preferential chan-
nels 254, 280, and 325 nm as the detection wavelengths.
Statistical analysis
The GraphPad Prism (GraphPad Software Inc., San Diego,
CA, USA) was used for data analysis and graphical pre-
sentations. All data are presented as the mean ± SEM.
Statistical analysis were performed by a one-way analysis
of variance (ANOVA) with Bonferroni’s corrected t test
for post-hoc pair-wise comparisons. P < 0.05 was consid-
ered as statistically significant.
Results
Characterization of the isolated GMSCs
GMSCs were isolated from gingival tissues from four
healthy female subjects (average age 35.5 years). The
cells were maintained in culture for 14–21 days and
characterized for their phenotypic and genotypic profile.
The primary cultures of single-cell suspensions exhibited a
fibroblast-like spindle cell shape and formed MSC-like col-
onies after 10–14 days of culture at a low density (Fig. 1a).
The GMSCs were analysed for their ability to form CFU-Fs,
and they produced a concentration-dependent increase in
colony formation of seeded GMSCs (Fig. 1b), confirming
that the gingival tissue-derived cells were clonogenic.
The isolated GMSCs exhibited long-term proliferation
capacity exceeding 12 passages in culture, and the
doubling-time at passage 4 was 35.7 ± 3.7 h in accord-
ance with literature data [33, 36].
The presence of specific GMSC markers were
evaluated by PCR analysis (Fig. 1c); the specific MSC-
associated surface markers CD90 and CD105 were highly
expressed. Conversely, the hematopoietic stem cell markers
CD34 and CD45 were not expressed (Fig. 1c). The expres-
sion of the specific GMSC marker CD90 was verified by
immunofluorescence (Fig. 1d) and Western blot analysis
(Fig. 1e, f). The CD90 protein expression was significantly
higher in isolated GMSCs with respect to the fibroblast cell
line (HuDe) (25.4 ± 3.2% vs. GMSC, P ≤ 0.001; Fig. 1e, f).
These results demonstrated that the isolated cells
shared a similar expression pattern with that of MSCs
derived from other tissues, such as from bone marrow
and dental pulp [36, 37].
GMSCs are characterized by their ability to differenti-
ate; thus, the osteogenic potential of the isolated cells
was examined. In the presence of osteogenic factors, the
gingival cells formed mineralized nodules or aggregates
(Fig. 1g, h). Calcium mineralization was confirmed by
Alizarin Red S staining that showed a significant in-
crease in osteogenic differentiation with respect to cells
cultured in growth medium (143.5% ± 11.0 vs. control,
P ≤ 0.01; Fig. 1h). Since these cells showed all the charac-
teristics of human MSCs, including phenotype, self-
renewal ability, and differentiation potential, these cells
were designated as the GMSC population.
TNF-α effects on GMSCs and HMEC-1 cells
The effects of a wide range of TNF-α concentrations
(0.1 ng/L to 100 ng/mL) on GMSC proliferation and
viability were evaluated after 48 or 72 h of cell treatment
(Fig. 2a, b and Additional file 1: Figure S1). The results
showed that TNF-α was able to slightly increase the
GMSC proliferation at a low concentration (5–10 ng/ml)
after 48 h. This effect was lost after 72 h of treatment.
Conversely, a high TNF-α concentration (100 ng/ml)
slightly decreased the GMSC proliferation after 48 h and
become significant after 72 h of treatment (P ≤ 0.05). More-
over, a neutral red assay demonstrated that the cytokine sig-
nificantly affects the numbers of living cells only after 72 h
of cell treatment, with a higher effect when the 100 ng/mL
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concentration was used (Additional file 1: Figure S1). These
data revealed that, under our experimental conditions,
TNF-α presented paradoxical effects on GMSCs dependent
on cell exposure time and cytokine concentration.
Neovascularization is necessary during all the phases
of wound healing. This occurs through endothelial cell
activation, proliferation, and migration [38, 39]. In this
process, a pivotal role is played by the MSCs that
Fig. 1 GMSC isolation and characterization. a Gingival tissues were digested and cultured for 14–21 days to obtain a selected population of
GMSCs. b Colony-forming unit fibroblast (CFU-F) assay. Cells were plated at densities of 500 or 1000 cells/well. After 14 days, the cells were fixed,
and stained with crystal violet. Groups of 50 or more cells were scored as colonies. The data are expressed as number of colonies, and are
presented as the mean values ± SEM of three independent experiments, each performed in duplicate. c GMSC mRNA was extracted and PCR
analysis of CD34, CD45, CD90, and CD105 was performed. Representative image of 2% agarose gel electrophoresis is shown. d GMSCs were fixed
to determine the CD90 expression by immunofluorescence staining with anti-CD90 antibody. DAPI was used to label cell nuclei. Representative
images are shown. e, f Expression of CD90 in GMSC and HuDe cells were evaluated by Western blot and a representative image (e) and
quantitative analysis performed using ImageJ (f) are reported. The data were expressed as the percentage of optical density (OD) versus control
set to 100% and represent the mean values ± SEM of three different experiments. The significance of the differences was determined by student
t test: ***P ≤ 0.001 versus GMSCs. g, h The osteogenic differentiation potential was evaluated using Alizarin Red staining. GMSCs were cultured in
osteogenic differentiation media for 21 days; at the end, the cells were stained and a representative photograph (10× magnified images) of
mineral nodules was captured. Top represents the mineralization when GMSC were mantained in growth medium, bottom after 21 days of
differentiation. (g). The amount of Alizarin Red S was quantified. The data are expressed as the percentage of osteogenic differentiation versus
cells cultured in proliferation medium, and are presented as the mean values ± SEM of three independent experiments, each performed in
duplicate. The significance of the differences was determined by student t test: ***P ≤ 0.001 vs. the control (CTRL)
Giacomelli et al. Stem Cell Research & Therapy  (2018) 9:135 Page 7 of 21
orchestrate the endothelial function through the release
of different cytokines and growth factors. In this respect,
the effects of a wide range of TNF-α concentrations (0.
1 ng/mL to 100 ng/mL) on HMEC-1 proliferation were
evaluated after 48 or 72 h of cell treatment (Fig. 2c, d).
The results showed that TNF-α (100 ng/mL) slightly de-
creased the HMEC-1 proliferation after 48 h, with this ef-
fect becoming significant after 72 h of treatment (Fig. 2d),
in accord with literature data [40]. The inflammatory cyto-
kine did not show any positive effects on endothelial cells,
but a high TNF-α concentration for a long period of
exposure could decrease the cell proliferation in accord
with the effects exerted on GMSCs.
The mechanism underlying the cell proliferation de-
crease was then investigated by evaluating the TNF-α
(100 ng/mL) apoptotic activity on GMSCs and HMEC-1
cells (Fig. 2e and Additional file 1: Figure S2). The 72 h
of treatment with a high TNF-α concentration was able
to induce a significant phosphatidylserine externalization
in the absence of 7-AAD staining (P ≤ 0.05), thus denot-
ing the signs of the early phase of apoptosis in both
GMSCs and endothelial cells (Fig. 2e).
Fig. 2 TNF-α effects on GMSC and HMEC-1 cell proliferation. GMSCs were treated in growth medium with different concentrations of tumour
necrosis factor (TNF)-α (1 ng/mL to 100 ng/mL) for a 48 h or b 72 h. Human microvascular endothelial cell (HMEC)-1 cells were treated in growth
medium with different concentrations of TNF-α (1 ng/mL to 100 ng/mL) for (c) 48 h or (d) 72 h. At the end of the treatments, the cell proliferation
was evaluated using the MTS assay, as described in the Methods. The data are expressed as the percentage versus the untreated cells (CTRL),
which was set to 100%, and are presented as the mean values ± SEM of three independent experiments, each performed in duplicate. e GMSCs
and HMEC-1 cells were treated in the absence or presence of TNF-α (100 ng/mL) after 72 h of cell treatments. At the end, cells were collected,
and the amount of phosphatidylserine externalization was evaluated using the Annexin V staining protocol. The distribution of the early and late
apoptotic cells is shown. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test: *P ≤ 0.05
vs. control
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Modulation of TNF-α on GMSC cytokine and growth
factor release
The GMSC secretome controls and modulates the activ-
ity of several other cell types. Classic growth factors and
cytokines, such as TGF-β, IL-10, IL-6, and COX2, serve
as paracrine control molecules secreted or packaged into
extracellular vesicles, or exosomes, by GMSCs [41, 42].
A computational STRING analysis was performed to in-
vestigate the functional interaction between NF-kB,
TNF-α, and the different cytokines released by the mes-
enchymal cells. Based on the criteria set, a network of
protein-protein interactions (PPI) that linked together
the NF-kB and the different cytokines/growth factors
were obtained (Fig. 3a).
Hereafter, TNF-α was used at the two concentrations
we previously demonstrated to exert opposite effects on
GMSC proliferation (Fig. 2). Challenging GMSCs with
TNF-α at 10 or 100 ng/mL caused a concentration-
dependent increase in pro-inflammatory cytokine release
(IL-6 and COX2; Fig. 3b, c) and a concentration-
dependent decrease of the anti-inflammatory cytokine
IL-10 levels (Fig. 3d). The growth factor TGF-β, which is
a well-known immunosuppressive cytokine [43], presented
a hermetic concentration-response course: TNF-α at
10 ng/ml concentration increased significantly the release
of the factor, whereas, the higher cytokine concentration
caused a slight decrease (69.5 ± 5.5, control; 97.6 ± 9.8,
TNF-α 10 ng/mL; 57.1 ± 2.9, TNF-α 100 ng/mL; Fig. 3e) of
the same factor.
TNF-α modulation of GMSC and endothelial cell interplay
The GMSC secretome inhibits inflammatory responses,
promotes endothelial and fibroblast activities, and facili-
tates the proliferation and differentiation of different
cells [44]. To investigate the effects of the GMSC secre-
tome on the endothelial cell functions, HMEC-1 were
treated with the conditioned medium (CM) derived by
the GMSCs (Fig. 4a). In particular, GMSCs were treated
for 24 h with a low (10 ng/ml) and high (100 ng/ml)
concentration of TNF-α; the collected medium was ap-
plied to HMEC-1 and, then, the endothelial cell prolifer-
ation and motility were analysed.
The CM derived by the GMSCs without treatment
(control CM) was able to promote endothelial cell prolif-
eration after 24 h (Fig. 4b) and, more efficiently, after
48 h of cell treatment (120.6 ± 2.6% vs control; Fig. 4b).
Furthermore, control CM was able to significantly in-
crease the endothelial cell motility (Fig. 4d–f ). These
data demonstrate that the GMSCs, per se, were able to
exert a trophic activity on the endothelial cells in accord-
ance with the reported trophic properties of GMSCs [18].
Next, the effects of TNF-α on the GMSC-HMEC-1
interplay were evaluated. A high concentration of
TNF-α (100 ng/mL) was able to modify the GMSC
secretome, producing a significant negative effect on
HMEC-1 proliferation (120.6 ± 2.6%, CM; 107.5 ± 4.4%,
TNF-α; Fig. 4b, c) and motility (56.4 ± 0.8%, CM; 49.7 ± 2.0%,
TNF-α; Fig. 4e, f ). Conversely, no significant effects
on HMEC-1 well-being or functionality were observed
Fig. 3 GMSC cytokine release under inflammatory conditions. a Interaction between NF-kB, tumour necrosis factor (TNF)-α and cytokines (interleukin
(IL)-6, IL-10, PTGS2 or cyclooxygenase (COX)-2 and transforming growth factor (TGF)-β1) performed at http://string-db.org/. b–e GMSCs were treated in
growth medium with different concentrations of TNF-α (10 ng/mL, 100 ng/mL) for 24 h. At the end of the treatments, the membrane COX-2 and the
IL-6, IL-10, and TGF- β1 levels in the medium were quantified using commercial ELISA kits. The data are reported as the mean values ± SEM of three
independent experiments each performed in duplicate. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s
post-hoc test: *P ≤ 0.05, ***P ≤ 0.001 vs. the control (CTRL)
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with a low dose of the cytokine, despite a positive
trend in the promotion of endothelial motility being
evident (Fig. 4). These results demonstrate that cyto-
kines such as TNF-α could turn off the beneficial and
trophic effects of GMSCs, negatively affecting their
interaction with surrounding cells dependent on time
and concentration.
Chemical composition of the bud preparation
The chemical composition of the RBE hydro-alcoholic
glycerine solution was investigated by means of HPLC-
PDA/UV-ESI-MS/MS techniques. The LC-PDA/UV
chromatogram, acquired at 325 nm, is shown in Fig. 5.
Compounds 1–14 (in Fig. 5a) were identified by com-
parison with their elution orders, ESI-MS/MS data, and
PDA/UV absorbance (Table 2) with data reported in the
literature. All identified molecules belong to the phenols
class, including phenolic acid derivatives, such as chloro-
genic acids (1, 3, and 4 in Fig. 5a), p-coumaroylquinic acids
(2, 5, and 7 in Fig. 5a), and flavonol glycosides, such as
myricetin 3-O-rutinoside (8 in Fig. 5a), myricetin 3-O-
glucoside and/or myricetin 3-O-galactoside (9 in Fig. 5a)
, quercetin 3-O-rutinoside (10 in Fig. 5a), quercetin 3-
O-glucoside and/or quercetin 3-O-galactoside (11 in
Fig. 5a), kaempferol 3-O-rutinoside (12 in Fig. 5a), kaemp-
ferol 3-O-glucoside (13 in Fig. 5a), and isorhamnetin gluco-
side and/or isorhamnetin galactoside (14 in Fig. 5a).
Compounds 1, 3, and 4 in Fig. 5a are three isomers
showing a similar mass spectra consisting of the same
parent ion [M −H]− at m/z 353 and different fragment
ions at m/z 191, due to the loss of the caffeoyl moiety,
179, generated by the loss of the quinic unit, 173,
Fig. 4 Effects of GMSC-conditioned medium (CM) on HMEC-1 proliferation and motility. a Schematic representation of the method. Human microvascular
endothelial cell (HMEC)-1 cells were grown in 80% HMEC-1 culture medium + 20% CM obtained from control and treated GMSCs, as reported in the
Methods, for b 24 h or c 48 h. At the end of the treatments, the cell proliferation was evaluated using the MTS assay. The data are expressed as the
percentage versus the untreated cells (CTRL), which was set to 100%, and they are presented as the mean values ± SEM of three independent experiments,
each performed in duplicate. d, e HMEC-1 cells were treated as above, and representative images of the scratch wounds at 0 h and 8 h are shown (d).
e The average length of the gaps of five scratch wounds was initially measured at 0 h (t0) and then after 8 h (t8). The data are presented as the mean
values ± SEM of at least two independent experiments performed in triplicate. **P ≤ 0.01, ***P ≤ 0.001 vs. the respective average gaps at t0. f Percentage of
gap closure compared with untreated cells (CTRL). The data are presented as the mean values ± SEM of at least two independent experiments performed
in triplicate. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test: *P ≤ 0.05 vs. control; #P ≤ 0.05
vs. the control CM (CTRL-CM). RBE, Ribes nigrum bud extract; TNF, tumour necrosis factor
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corresponding to a product ion [quinic acid−H −H2O]
−,
and 135, due to a [caffeic acid−H −CO2]
− ion. These
data are in agreement with those reported for these
compounds by Clifford et al. [45]. The presence of 3-O-
caffeoylquinic acid (neochlorogenic acid), 4-O-caffeoylquinic
acid (cryptochlorogenic acid), and 5-O-caffeoylquinic
acid (chlorogenic acid) in RBE buds was recently
reported [46, 47]. Peaks 2, 5, and 7 in Fig. 5a (λmax 313–314)
displayed the same full mass spectra with deprotonated
molecules [M −H]− at m/z 337. MS/MS spectra have a
similar fragmentation pathway, showing fragment ions at
m/z 173, due to the loss of a p-coumaric acid molecule
([M − 164]−), and two other diagnostic ions at m/z 191
and 163, in accord with the fragmentation profile of
p-coumaroylquinic acids [48]. These finding are in
agreement with the study of Ieri et al. who reported the
presence of p-coumaroylquinic acid isomers in commercial
bud preparations of blackcurrant [47]. It is possible to
discriminate between each of the three isomers on the
basis of the base peak value generated in the MS/MS
spectra, according to Clifford et al. [48]. Indeed, base peaks
at m/z 163, 173, and 191 were generated by fragmentation
of p-coumaroylquinic acid parent ions carrying the
esterification at position 3, 4, and 5, respectively. Thus,
compounds 2, 5, and 7 could be identified as 3-p-
coumaroylquinic acid, 4-p-coumaroylquinic acid, and 5-p-
coumaroylquinic acid, respectively.
Peaks 8–14 in Fig. 5a were assigned to flavonoid glyco-
sides showing characteristic UV spectra, with two strong
absorption peaks at 255–270 and 349–358 nm, typical of a
flavonol structure. Aglycon portions were represented by
myricetin, kaempferol, quercetin, and isorhamnetin as de-
duced by fragment ions in the MS/MS spectra at m/z 317,
285, 301, and 315, respectively. Parent ions ([M −H]−) of
flavonoid monoglycosides at m/z 479 (9 in Fig. 5a), 463 (11
in Fig. 5a), 447 (13 in Fig. 5a), and 477 (14 in Fig. 5a)
displayed product ions generated by the loss of one hexose
moiety ([M − 162]−) due to the cleavage of O-sugar bond.
MS/MS spectra of compounds 8 and 10 in Fig. 5a showed
product ions generated by the loss of one rhamnose moiety
Fig. 5 Composition and anti-inflammatory effect of RBE. a LC-PDA/UV chromatogram (detected at 325 nm) of Ribes nigrum bud extract (RBE)
preparation. For peak data, see Table 2. b GMSCs or human microvascular endothelial cell (HMEC)-1 cells were treated with RBE (50 μg/mL) for
24 h. At the end of the incubation, NF-kB and tumour necrosis factor (TNF)-α expression levels were detected by real time RT-PCR. The data are
expressed as the fold of change versus the control (CTRL), which were set to 1, and are presented as the mean values ± SEM of three independent
experiments. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test: **P ≤ 0.01, vs. control
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([M − 146]−) and one hexose moiety ([M − 162]−)
attributable to the presence of the disaccharide rutinose
linked to the myricetin and quercetin aglycons, respectively.
Thus, compounds 8 and 10 were identified as myricetin 3-
O-rutinoside and quercetin 3-O-rutinoside, respectively.
The detection of all these bioactive constituents was in
agreement with results previously reported [46, 47].
The MS/MS experiment for peak 6 in Fig. 5a ([M −H]−
at m/z 609) provided product ions at m/z 447 and 285,
generated by the subsequent losses of two hexose moieties,
not identifiable through spectral data; thus compound 6
was supposed to be a kaempferol di-hexoside by PDA/UV
and MS/MS data [49].
R. nigrum anti-inflammatory effects on GMSCs and HMEC
cells
The anti-inflammatory properties of RBE [31], and the
effects of some of its constituents on inflammatory gene
transcription such as NF-kB and TNF-α [50–52], have
been demonstrated. Inflammation is a pivotal process
that may positively or negatively affect regenerative pro-
cesses and the different cell types involved [53]. Thus,
the ability of the RBE to modulate NF-kB and TNF-α
gene transcription was evaluated in both GMSCs and
HMECs (Fig. 5b).
Challenging the GMSCs with the RBE (50 μg/mL) for
24 h produced a significant decrease in NF-kB (0.60 ± 0.09
fold with respect to control, P ≤ 0.001) gene expression, and
only a slight decrease in TNF-α transcription. In HMEC-1
cells treated with RBE (50 μg/mL) for 48 h, the NF-kB ex-
pression was significantly decreased (0.54 ± 0.09 fold with
respect to control, P ≤ 0.001) as well as the TNF-α expres-
sion (0.62 ± 0.10 fold with respect to control, P ≤ 0.001),
which is one of the pro-inflammatory cytokines mainly af-
fecting the endothelial cell fate [54]. Taken together, these
results demonstrated that RBE has anti-inflammatory ef-
fects on GMSCs and HMEC-1 cells, negatively modulating
pro-inflammatory pathways.
Effects of R. nigrum on GMSC and HMEC-1 cell
proliferation and well-being
To investigate the putative effects of RBE on stem cell
proliferation/viability, isolated GMSCs were treated with
a wide range of the extract concentrations (100 ng/mL
to 100 μg/mL) for 48 and 72 h. The results (Fig. 6a, b)
showed that higher concentrations of RBE slightly af-
fected the GMSC proliferation after 48 h of cell treat-
ment and the effects become significant only after 72 h.
The proliferative effects were dose-dependent, with a
maximum increase of 123.3 ± 2.5% (50 μg/mL) of cell
Table 2 Spectral (UV and ESI-MS/MS) and chromatographic data (retention time, tR) of phenols (1–14) detected in R. nigrum
bud preparation
Peak Compound tR (min) M [M − H]
− MS/MS base peak (m/z) MS/MS ions (m/z) λmax (nm)
Phenolic acids
1 Caffeoylquinic acid 17.7 354 353 179 191, 173, 135 257, 325
2 3-p-Coumaroylquinic acid 25.2 338 337 163 293, 203, 191,173 313
3 Caffeoylquinic acid 29.6 354 353 179 191, 173, 155, 135 257, 329
4 Caffeoylquinic acid 32.3 354 353 191 179, 173, 135 257, 329
5 4-p-Coumaroylquinic acid 41.6 338 337 173 293, 191, 173, 163, 155 313
7 5-p-Coumaroylquinic acid 45.8 338 337 191 293, 207, 173, 163 314
Flavonol glycosides
6 Kaempferol di-hexoside 44.4 610 609 447 573, 489, 285, 179 270, 356
8 Myricetin 3-O-rutinoside 55.1 626 625 317 607, 479, 271, 243, 203, 179 270, 357
9 Myricetin 3-O-glucoside and/or
myricetin 3-O-galactoside
55.9 480 479 317 461, 271, 179, 151 269, 358





62.3 464 463 301 445, 273, 179 257, 356
12 Kaempferol 3-O-rutinoside 66.3 594 593 285 447, 257, 229, 179 270, 350
13 Kaempferol 3-O-glucoside
(astragalin)
67.1 448 447 285 257, 229, 179 268, 349
14 Isorhamnetin glucoside and/or
isorhamnetin galactoside
67.8 478 477 315 285, 271, 243, 229, 179 271, 356
Compound numbers correspond with peak numbers in Fig. 5
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growth. Moreover, a neutral red assay demonstrated that
the extract significantly affected the numbers of living
cells only after 72 h of cell treatment, with the higher
effect when the 50 μg/mL concentration was used
(Additional file 1: Figure S1). These data show the ability
of RBE to affect the proliferation of the GMSCs, increas-
ing the cell number in a dose- and time-dependent
manner. The induction of MSC proliferation and the
maintenance of stemness features represents a pivotal
mechanism for improving the regenerative properties of
the MSCs [55].
The role of the transcription factors that regulate self-
renewal and differentiation is well known in embryonic
stem cells [56]. Among these, Oct4 (octamer-binding
transcription factor 4) and SOX2 (sex determining re-
gion Y (SRY)-box 2) work together to support each
other’s expression and that of other self-renewal genes
repressing differentiation genes [57, 58]; thus, the effects
of RBE on the expression of Oct4 and SOX2 stemness
genes were investigated (Fig. 6c). In parallel, the expres-
sion of mammalian target of rapamycin (mTOR) that
was involved in MSC differentiation was quantified.
GMSC treatment with RBE (50 μg/mL) did not signifi-
cantly affect mTOR expression (Fig. 6c). Conversely, it was
able to significantly increase the gene expression of the
stemness markers Oct4 and SOX2 (1.8 ± 0.3 and 1.7 ± 0.1
fold change, respectively). Taken together, these results
demonstrated the positive effect of the RBE on GMSC
well-being, promoting stemness maintenance.
To investigate the effects of RBE alone on the prolifer-
ation/viability of endothelial cells (HMEC-1), cells were
treated with different concentrations of RBE (100 ng/mL
to 100 μg/mL) for 48 or 72 h. The results (Fig. 6d–f )
showed that it affected the HMEC-1 proliferation at
higher concentrations after 24 h of cell treatment in a
concentration-dependent manner, with an EC50 value of
34.5 μg/mL. This effect become more evident after 48
and 72 h, with an increase in both the EC50 values (27.4
and 21.0 μg/mL, respectively) and the maximum effects
(147.7 ± 7.6% and 162.0 ± 1.7%, respectively). These data
show the ability of RBE to affect the proliferation of
HMEC-1 cells. Interestingly, the endothelial cells showed
a higher sensitivity to the extract exposure per se with
respect to the GMSCs (Fig. 6a, b).
Fig. 6 RBE effects on GMSC and HMEC-1 cell proliferation and stemness gene expression. GMSCs were treated in growth medium with different
concentrations of Ribes nigrum bud extract (RBE; 100 ng/mL to 100 μg/mL) for a 48 h or b 72 h. At the end of the treatments, the cell proliferation was
evaluated using the MTS assay. The data are expressed as the percentage versus the untreated cells (CTRL), which was set to 100%, and are presented
as the mean values ± SEM of three independent experiments, each performed in duplicate. c GMSCs were treated with RBE (50 μg/mL) for 24 h. At
the end of the incubation, a real time RT-PCR analysis of mTOR, Oct4, and SOX2 was performed. The data are expressed as the fold change versus the
control (CTRL) levels (without RBE), which were set to 1, and are presented as the mean values ± SEM of three different experiments. Human
microvascular endothelial cell (HMEC)-1 cells were treated in growth medium with different concentrations of RBE (100 ng/mL to 100 μg/mL) for d
48 h or e 72 h. At the end of the treatments, the cell proliferation was evaluated using the MTS assay, as described in the Methods. The data are
expressed as the percentage versus the untreated cells (CTRL), which was set to 100%, and they were presented as the mean values ± SEM of three
independent experiments, each performed in duplicate. f Non-linear regression with variable slope of the RBE concentration-response curve at the
different times. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test: *P ≤ 0.05, **P ≤ 0.01,
***P ≤ 0.001 vs. control
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R. nigrum decrease the negative effects of TNF-α in
GMSCs and HMEC-1 cells
To fully investigate the effects of TNF-α on GMSC
trophic activity, the RBE was used as anti-inflammatory
agent since it had been demonstrated to interfere with
the inflammatory pathways in GMSCs and HMEC-1
cells, promoting their well-being. RBE cell treatment for
72 h in the presence of 100 ng/ml TNF-α completely
counteracted the cytokine effects on GMSC pro-
liferation, restoring the cell growth rate as demon-
strated by MTS and neutral red assays (Fig. 7a, b and
Additional file 1: Figure S2).
Next, the effects of RBE on TNF-α-induced blockade of
HMEC-1 cell proliferation and viability were evaluated
(Fig. 7c, d). The extract per se increased the HMEC-1 via-
bility; interestingly, RBE was able to completely counteract
the negative effects of 100 ng/mL TNF-α, restoring the
cell growth rate. Taken together, these results suggest that
RBE exerts a cyto-protective effect in an experimental
model of inflammation counteracting the negative effects
exerted by a high TNF-α concentration, both in human
GMSCs and, more markedly, in endothelial cells.
Restoration of GMSC cytokine and growth factor release
by R. nigrum
First, the putative effects of RBE alone on the GMSC
secretome were investigated (Fig. 8). Isolated GMSCs were
treated with RBE (50 μg/mL) for 24 h and quantitative ana-
lysis of the released cytokines was performed. The unstimu-
lated GMSCs secreted low levels of anti-inflammatory
molecules (TGF-β and IL-10), and RBE alone was not able
to alter their expression pattern (Fig. 8). Thus, RBE per se
was not able to alter the trophic function of GMSCs.
Then, GMSCs were treated with an inflammatory
stimulus (TNF-α 100 ng/mL) in the presence of RBE.
The presence of RBE was able to significantly reduce the
release of IL-6 and the expression of COX2, with levels
comparable with that obtained with a low TNF-α
(10 ng/mL) stimulation. RBE significantly increased IL-
10 release and expression. Finally, RBE was able to only
partially increase TGF-β. Furthermore, in a radar plot,
a shift of the cytokine production versus the basal
condition was shown (Fig. 8i). These results highlight
that RBE is able to modulate the inflammatory
process. Furthermore, the extract did not completely
block the cytokine release but only restored the levels
necessary to mediate the positive effect of a con-
trolled inflammation.
GMSC and endothelial cell interplay is modulated by
R. nigrum extract
Considering that RBE promotes anti-inflammatory actions
through the modulation of the GMSC secretome, the ex-
tract effects on GMSC-HMEC-1 cell interplay was evalu-
ated by the CM method (Fig. 9). The extract alone did not
modify the HMEC-1 cell proliferation (Fig. 9a, b) in ac-
cord with the absence of the GMSC secretome compos-
ition; interestingly, RBE was able to completely counteract
the negative effects of TNF-α (100 ng/mL) on HMEC-1
cells, restoring the levels of cell growth rate triggered by
GMSC control CM. GMSC-CM and TNF-α (100 ng/mL)
produced comparable effects on HMEC-1 motility to that
reported above (Fig. 4d–f ). Furthermore, the treatment of
GMSCs with the extract alone produced a CM that did
not modify endothelial cell motility (Fig. 9c–e), in agree-
ment with the lack of effects on GMSC cytokine release
(Fig. 8). Surprisingly, in the presence of a highly inflamma-
tory microenvironment, RBE was able to significantly
Fig. 7 RBE modulation of TNF-α activity on GMSCs and HMEC-1 cells.
GMSCs were treated in growth medium with different concentrations of
tumour necrosis factor (TNF)-α (1 ng/mL to 100 ng/mL) in the absence
or the presence of the Ribes nigrum bud extract (RBE; 50 μg/mL) for a
48 h or b 72 h. Human microvascular endothelial cell (HMEC)-1 cells
were treated in growth medium with different concentrations of
TNF-α (1 ng/mL to 100 ng/mL) in the absence or the presence of RBE
(50 μg/mL) for c 48 h or d 72 h. At the end of the treatments, the cell
proliferation was evaluated using the MTS assay, as described in the
Methods. The data are expressed as the percentage with respect to
the untreated cells (CTRL), which was set to 100%, and are presented
as the mean values ± SEM of three independent experiments, each
performed in duplicate. The significance of the differences was
determined by one-way ANOVA, followed by Bonferroni’s post-hoc test
or student t test: *P ≤ 0.05, **P ≤ 0.01 vs. control (CTRL); #P ≤ 0.05, ##P ≤
0.01 vs. the respective TNF-α
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counteract the negative effects of the high concentration
of TNF-α. These results suggest that the use of natural
agents, such as RBE, are able to counteract the effects of a
high TNF-α concentration, restoring the GMSC secre-
tome similarly to that obtained in controlled inflam-
mation (a low TNF-α dose) which could effectively be
used to modulate the GMSC response during the re-
generative process. In particular, these results demon-
strate a necessity for controlling the inflammatory
priming of GMSCs during the regenerative process
both in vivo and in vitro when GMSCs are used in
engineering grafts.
Discussion
Recently, great attention has been paid to the use of MSCs
in regenerative medicine and to the discovery of agents
able to modify the well-being and functionality of these
particular kinds of cells [18]. In this study, the effects of
TNF-α used at different concentrations were evaluated on
GMSC and endothelial cell well-being, demonstrating its
paradoxical effects. Low concentrations positively en-
hanced the well-being of these cells that are pivotal actors
in tissue repair; conversely, a high concentration pro-
moted the release of high amounts of inflammatory cyto-
kines thus negatively affecting the regenerative properties
of GMSCs. Furthermore, we demonstrated that the use of
natural compounds, such as RBE which were able to
modulate the inflammatory pathways, counteracted the
negative influence of TNF-α on GMSC-endothelial cell
cross-talk, modulating the GMSC secretome com-
position probably through the modulation of NF-kB
gene expression.
Fig. 8 RBE modulation of GMSC cytokine release under normal and inflammatory conditions. a–h GMSCs were treated in growth medium with
different concentrations of tumour necrosis factor (TNF)-α (10 ng/mL, 100 ng/mL) in the absence or the presence of Ribes nigrum bud extract
(RBE; 50 μg/mL) for 24 h. a–d At the end of the treatments, the membrane cyclooxygenase (COX)-2 and the interleukin (IL)-6, IL-10, and
transforming growth factor (TGF)-β1 levels in the medium were quantified using ELISA kits. The values are presented as the mean values ± SEM
of three different experiments. e–h GMSCs, treated as above, were lysed and real-time RT-PCR analysis of IL-6, IL-10, COX-2, and TGF- β1 was
performed. The data are expressed as the fold of change versus the untreated cells (CTRL), which were set to 1, and are presented the mean values ±
SEM of three different experiments. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test:
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 vs. control (CTRL); #P ≤ 0.05, ##P ≤ 0.01, ###P ≤ 0.001 vs. the respective TNF-α. i The radar plot shift of the cytokine
production
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The role of MSCs in the regenerative process has been
widely studied [59]. Despite the main function of MSCs
is their differentiation ability, the therapeutic effects of
MSCs may also depend on their capability to regulate in-
flammation and tissue homeostasis [16, 55, 60]. Pres-
ently, BM is considered as a prime source of MSCs,
although their isolation is an invasive procedure for both
patients and donors. BM-MSCs enter senescence and
lose their stem cell characteristics early in culture [61].
Thus, several studies have been undertaken to find
appropriate alternatives. Gingiva is a tissue with a high
regenerative capacity and has been highlighted as one
possible source of MSCs [18, 62]. Considering the func-
tion and characteristics of GMSCs, they have become an
exciting alternative for tissue engineering approaches,
aiming to enhance wound repair in oral and extra-oral
tissues [18]. In fact, the GMSCs are able to accelerate
the repair process in a murine excisional full-thickness
skin wound model [63]. Herein, the GMSC cultures
were easily obtained by biopsies from healthy subjects,
and the isolation procedure lead to a homogenous
culture of mesenchymal cells as previously described
Fig. 9 Modulatory effects of Ribes nigrum bud extract (RBE) on GMSC-HMEC-1 interplay. a, b HMEC-1 cells were grown in 80% HMEC-1 culture
medium + 20% conditioned medium (CM) obtained from control (CTRL) and treated GMSCs, as reported in the Methods, for a 24 h or b 48 h. At
the end of the treatments, the cell proliferation was evaluated using the MTS assay. The data are expressed as the percentage versus the control
cells (CTRL CM), which was set to 100%, and are presented as the mean values ± SEM of three independent experiments, each performed in
duplicate. c HMEC-1 cells were treated as above, and representative images of the scratch wounds at 0 h and 8 h are shown. d The average
length of the gaps of five scratch wounds was initially measured at 0 h (t0) and then after 8 h (t8). The data are presented as the mean values ±
SEM of at least two different experiments performed in triplicate. **P ≤ 0.01, ***P ≤ 0.001 vs. the respective average gaps at t0. e Percentage of gap
closure compared to control cells (CTRL). The data are presented as the mean values ± SEM of at least two different experiments performed in
triplicate. The significance of the differences was determined by one-way ANOVA, followed by Bonferroni’s post-hoc test: *P ≤ 0.05, **P ≤ 0.01 vs.
control; #P ≤ 0.05 vs. tumour necrosis factor (TNF)-α 100 ng/mL
Giacomelli et al. Stem Cell Research & Therapy  (2018) 9:135 Page 16 of 21
[33, 36]. These cells could differentiate in bone and ex-
press the typical surface markers of mesenchymal cells,
in accordance with the literature data [61].
Inflammation is a pivotal phase in normal tissue
repair; however, pathologically chronic and extensive in-
flammation causes detrimental effects leading to the dis-
ruption of the normal healing cascade [64]. MSCs have
been widely described as the guardian of the inflamma-
tory process due to their ability to modulate the immune
response and promote wound healing [65]. Accordingly,
it has been demonstrated that the pro-inflammatory
cytokine TNF-α exerts opposite and conflicting effects on
MSCs, primarily depending on its concentration and time
of cell exposure [66–68]. In our experimental model, a low
TNF-α concentration (10 ng/mL) or a low time of cell ex-
posure (24–48 h) does not negatively affect the prolifera-
tion of GMSCs, in accordance with the literature [69]. In
gingival tissue, chronic inflammation is one of the main
causes of gingival hyperplasia that is the result of robust
cell proliferation [70]. However, the amounts of inflamma-
tory cytokines, such as TNF-α, even if they are significantly
increased in gingival tissue of gingivitis and periodontitis
patients, remains in the low nanomolar/picomolar range
[71]. This supports the positive effects exerted by a low
TNF-α concentration on GMSC proliferation in our cellu-
lar model. Conversely, a high concentration of the cytokine
(100 ng/mL) for a longer time (72 h), which could mimic a
prolonged exposure to a pathological inflammatory state,
produces a significant decrease in cell proliferation. It has
been reported that TNF-α induces apoptosis in several cell
types [72–75]. In our cellular model, the decrease in
GMSC proliferation could be explained by a slight increase
in apoptotic processes, despite the possibility of other
mechanisms of cell death that could not be excluded. In
fact, MSCs, when maintained in culture, undergo a prema-
ture senescence, thus limiting their use in cell therapy [76].
The use of external stressor such as radiation, reactive oxy-
gen species (ROS), and cytokines could promote not only
the apoptotic process but also senescence in MSCs [77,
78]. Further studies are in progress to fully investigate the
possible role of TNF-α in induced-GMSC senescence.
Recently, increasing evidence indicates that MSCs
exert their beneficial effects by secreting paracrine or
trophic factors [55], as demonstrated by the ability of
MSC-conditioned media to induce wound healing [79].
MSC-conditioned medium contains several cytokines,
growth factors, and exosomes, containing miRNAs,
mRNAs, and proteins, that can be transferred as a type
of “physiological lipofection” to recipient cells and modi-
fying their characteristics [80–82]. In this respect, it has
been demonstrated that the trophic role of the GMSCs
is mainly due to the modulation of cytokines such as IL-6,
TGF-β, prostaglandin E2, and vascular endothelial growth
factor (VEGF) [2, 83]. These secreted factors may inhibit
inflammatory responses, promote fibroblast activities, fa-
cilitate the proliferation and differentiation of progenitor
cells in tissues, and promote angiogenesis which is neces-
sary to support the regenerative process by maintaining an
adequate tissue oxygenation [44, 84]. In our experimental
setting, challenging GMSCs with a low TNF-α (10 ng/mL)
concentration promoted the secretion of low amounts of
pro-inflammatory cytokines and increased the release of
TGF-β leading to a positive effect on endothelial prolifera-
tion and motility. Conversely, a high concentration of
TNF-α significantly modified the release of different cyto-
kines and growth factors (IL-6, IL-10, TGF-β, and COX-2)
towards a pro-inflammatory microenvironment. The
modification of the GMSC secretome produced a negative
effect on endothelial cell function (proliferation and
motility). These results reflect the well-established
opposite effect of TNF-α, demonstrating the importance
of controlling the cytokine concentration in in-vitro
applications to promote the function of MSCs [85] and to
control the inflammatory microenvironment during the
wound-healing process.
Different approaches have been utilized to harness the
trophic function of MSCs [86]. Numerous innovative
and conventional biological agents, including traditional
oriental herbal medicines, have recently been tested for
their preconditioning effect in vitro in an attempt to im-
prove the cellular properties and regenerative treatment
outcome of GMSCs in vivo [18]. Extracts of plants and
fruits such as Ligustrum lucidum, Herba epimedii, or
Cissus quadrangularis have been demonstrated to affect
the differentiation/proliferation and trophic activity of
MSCs [87]. However, to date no data have been reported
on the RBE biological activity properties on GMSCs and
endothelial cells.
In the current study, the chemical composition of the
RBE showed a high content of phenols that have been
reported to possess anti-inflammatory activity [88, 89].
Results from the HPLC-PDA/UV-ESI-MS/MS analyses
revealed that RBE is rich in phenol constituents (Table 2)
, in agreement with data previously reported [28]. In par-
ticular, phenolic acid derivatives and flavonol mono- and
di-glycosides were revealed. Compounds 1, 3, and 4
(λmax 257 and 325–329 nm) were identified as caffeoyl-
quinic acids. Compounds 2, 5, and 7 can be identified as
3-p-coumaroylquinic acid, 4-p-coumaroylquinic acid, and
5-p-coumaroylquinic acid, respectively. Finally, compounds
8–14 were identified as myricetin 3-O-rutinoside (8), myri-
cetin 3-O-glucoside and/or myricetin 3-O-galactoside (9),
quercetin 3-O-rutinoside or rutin (10), quercetin 3-O-
glucoside and/or quercetin 3-O-galactoside (11), kaemp-
ferol 3-O-rutinoside (12), kaempferol 3-O-glucoside (13),
and isorhamnetin glucoside and/or isorhamnetin galacto-
side (14). The detection of all these bioactive constituents
was in agreement with results previously reported [46, 47].
Giacomelli et al. Stem Cell Research & Therapy  (2018) 9:135 Page 17 of 21
Several flavonols have been reported to exhibit
controversial effects on cell proliferation depending
on the cell type and dose. Kaempferol is able to in-
crease human fibroblast proliferation when applied at
a low concentration. Conversely, at a high dose it in-
duces a significant decrease in cell growth [90]. Simi-
lar effects have been reported for quercetin in several
cell types [91–93]. Herein, for the first time, the abil-
ity of RBE to promote GMSC and endothelial cell
proliferation was reported. The positive action of RBE
on mesenchymal cell well-being was confirmed by the
significant increase in stemness gene transcription,
such as Oct4 and SOX2. In fact, it is well known that
the expression of such genes is pivotal for the suc-
cessful establishment of the pluripotent state and the
maintenance of adult stem cells [94]. The discordance
between the effects reported for the single constitu-
ents and the total extract could be explained by the
difference in the constituent concentration when used
alone or as part of the total extract. In fact, the con-
centrations of each phytochemical in the total extract
remain lower, and the final biological effects could
derive from the combination of the positive effects
exerted by these low concentrations.
The RBE demonstrated the ability to counteract the
negative effect of TNF-α, restoring the cytokine release
pattern of untreated GMSCs. This is in accordance with
the effects of the quercetin on orbital fibroblasts, where
it is able to decrease the inflammatory-induced expres-
sion of IL-6 and COX-2, and to increase IL-10 through
the decrease of NF-kB activation [95]. Similar effects
have been reported for kaempferol in chondrocyte and
macrophages [96, 97].
Conclusions
Taken together, these data shed light on the role of
TNF-α on GMSC well-being and trophic activity. In the
scenario of regenerative medicine and in the search for
pre-conditioned agents able to modify the secretome of
these cells, the present study demonstrates how the
extracellular microenvironment could differently affect
the functionality of GMSCs dependent on time of
exposure and concentration. In parallel, these data
demonstrate the positive effects of RBE to enhance the
well-being of the stem cells and to increase their trophic
activity. Nevertheless, the effects on several other cyto-
kines and growth factors involved in wound healing pro-
cesses should be fully investigated; these data highlight
the importance of modulating the inflammatory priming.
Furthermore, the modulation of the cellular microenvir-
onment using natural products was demonstrated to be
able to alter inflammatory responses, favouring the
regenerative pathways. This study also opens the way to
a full investigation of RBE and its single components for
the development of an effective formulation able to im-
prove wound healing in oral and extra-oral tissues or to
enhance in-vitro stem cell properties as tools for
engineering graft applications.
Additional file
Additional file 1: Figure S1. The effects of TNF-α on GMSCs and Ribes
nigrum modulation of the inflammatory cytokine activity. A–D) GMSCs
were treated in growth medium with different concentrations of TNF-α
(1 ng/mL to 100 ng/mL) in the absence or presence of Ribes nigrum bud
extract (RBE; 50 μg/mL) for 48 h (A, C) or 72 h (B, D). At the end of the
treatments, the live cells were quantified using the neutral red assay, as
described in the Methods. The data are expressed as a percentage with
respect to the untreated cells (CTRL), which was set to 100%, and are
presented as the mean values ± SEM of three independent experiments,
each performed in duplicate. The significance of the differences was
determined by one-way ANOVA, followed by Bonferroni’s post-hoc test
or student t test: *P ≤ 0.05, **P ≤ 0.01 vs. the control; #P ≤ 0.05, ##P ≤ 0.01
vs. the respective TNF-α. Figure S2. Apoptotic effects of TNF-α. GMSCs
(A, B) and HMEC cells (C, D) were treated for 72 h; at the end, cells were
collected, and the amount of phosphatidylserine externalization was
evaluated using the Annexin V staining protocol. Representative plots of
control (CTRL; A, C) and TNF-α 100 ng/mL (B, D) are presented. (DOCX 206 kb)
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